Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more
Market Cap & Net Worth: Coloplast A/S (CLPBF)
Coloplast A/S (PINK:CLPBF) has a market capitalization of $20.65 Billion ($20.65 Billion) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #1284 globally and #977 in its home market, demonstrating a -5.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Coloplast A/S's stock price $99.57 by its total outstanding shares 207366796 (207.37 Million).
Coloplast A/S Market Cap History: 2015 to 2025
Coloplast A/S's market capitalization history from 2015 to 2025. Data shows growth from $11.93 Billion to $20.65 Billion (7.21% CAGR).
Coloplast A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Coloplast A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.74x
Coloplast A/S's market cap is 0.74 times its annual revenue
169.88x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
5.69x
Coloplast A/S's market cap is 5.69 times its annual earnings
830.37x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $10.24 Billion | $14.68 Billion | $3.14 Billion | 0.70x | 3.26x |
| 2017 | $13.45 Billion | $15.53 Billion | $3.80 Billion | 0.87x | 3.54x |
| 2018 | $15.82 Billion | $16.45 Billion | $3.85 Billion | 0.96x | 4.11x |
| 2019 | $23.02 Billion | $17.94 Billion | $3.87 Billion | 1.28x | 5.94x |
| 2020 | $29.03 Billion | $18.54 Billion | $4.20 Billion | 1.57x | 6.92x |
| 2021 | $33.60 Billion | $19.43 Billion | $4.83 Billion | 1.73x | 6.96x |
| 2022 | $23.08 Billion | $22.58 Billion | $4.71 Billion | 1.02x | 4.90x |
| 2023 | $23.84 Billion | $24.50 Billion | $4.78 Billion | 0.97x | 4.99x |
| 2024 | $26.66 Billion | $27.03 Billion | $5.05 Billion | 0.99x | 5.28x |
| 2025 | $20.65 Billion | $27.82 Billion | $3.63 Billion | 0.74x | 5.69x |
Competitor Companies of CLPBF by Market Capitalization
Companies near Coloplast A/S in the global market cap rankings as of March 19, 2026.
Key companies related to Coloplast A/S by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Coloplast A/S Historical Marketcap From 2015 to 2025
Between 2015 and today, Coloplast A/S's market cap moved from $11.93 Billion to $ 20.65 Billion, with a yearly change of 7.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $20.65 Billion | -22.56% |
| 2024 | $26.66 Billion | +11.81% |
| 2023 | $23.84 Billion | +3.32% |
| 2022 | $23.08 Billion | -31.31% |
| 2021 | $33.60 Billion | +15.71% |
| 2020 | $29.03 Billion | +26.14% |
| 2019 | $23.02 Billion | +45.49% |
| 2018 | $15.82 Billion | +17.62% |
| 2017 | $13.45 Billion | +31.32% |
| 2016 | $10.24 Billion | -14.14% |
| 2015 | $11.93 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Coloplast A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.65 Billion USD |
| MoneyControl | $20.65 Billion USD |
| MarketWatch | $20.65 Billion USD |
| marketcap.company | $20.65 Billion USD |
| Reuters | $20.65 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.